Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

An antibody-based leukocyte-capture microarray for the diagnosis of systemic lupus erythematosus.

Lin MW, Ho JW, Harrison LC, dos Remedios CG, Adelstein S.

PLoS One. 2013;8(3):e58199. doi: 10.1371/journal.pone.0058199. Epub 2013 Mar 13.

2.

Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: beyond biomarker discovery.

Ho JW, Lin MW, Braet F, Su YY, Adelstein S, dos Remedios CG.

Proteomics Clin Appl. 2010 Feb;4(2):179-89. doi: 10.1002/prca.200900165. Epub 2009 Dec 2. Review. Erratum in: Proteomics Clin Appl. 2010 Jul;4(6-7):679. Braet, Filip [added]; Su, Ying Ying [added].

PMID:
21137042
3.

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Julkunen H, Ekblom-Kullberg S, Miettinen A.

Rheumatol Int. 2012 Aug;32(8):2445-51. doi: 10.1007/s00296-011-1962-3. Epub 2011 Jun 26.

PMID:
21706294
4.

Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.

Bizzaro N, Villalta D, Giavarina D, Tozzoli R.

Autoimmun Rev. 2012 Dec;12(2):97-106. doi: 10.1016/j.autrev.2012.07.002. Epub 2012 Jul 15. Review.

PMID:
22810055
5.
6.
7.

Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.

Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.

Int J Rheum Dis. 2009 Jul;12(2):100-6. doi: 10.1111/j.1756-185X.2009.01391.x.

PMID:
20374326
8.

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.

Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.

Rheumatology (Oxford). 2004 Feb;43(2):220-4. Epub 2003 Sep 16.

9.

[The autoantibody profile and disease activity in patients with systemic lupus erythematosus].

Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.

Vnitr Lek. 1997 Oct;43(10):639-44. Czech.

PMID:
9601876
10.

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.

Fu Q, Chen X, Cui H, Guo Y, Chen J, Shen N, Bao C.

Arthritis Res Ther. 2008;10(5):R112. doi: 10.1186/ar2510. Epub 2008 Sep 15.

11.

Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.

Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M.

Arthritis Care Res (Hoboken). 2011 Jun;63(6):891-8. doi: 10.1002/acr.20446.

12.

Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.

Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.

Clin Rheumatol. 2003 Oct;22(4-5):271-8.

PMID:
14576989
13.

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR.

Immunology. 2010 Jul;130(3):337-43. doi: 10.1111/j.1365-2567.2010.03245.x. Epub 2010 Feb 26.

14.
15.
16.

Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.

Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.

Scand J Rheumatol. 2007 Jul-Aug;36(4):291-8.

PMID:
17763207
17.

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.

Arthritis Res Ther. 2009;11(5):R156. doi: 10.1186/ar2833. Epub 2009 Oct 15.

18.

The use of laboratory tests in the diagnosis of SLE.

Egner W.

J Clin Pathol. 2000 Jun;53(6):424-32. Review.

19.

Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile.

Carmona-Fernandes D, Santos MJ, Canhão H, Fonseca JE.

BMC Med. 2013 Apr 4;11:98. doi: 10.1186/1741-7015-11-98.

20.

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.

Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.

Arthritis Rheum. 2012 Dec;64(12):4040-7. doi: 10.1002/art.34669.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk